Phase 2 REVIVE Clinical Trial for Polycythemia Vera

Arturo Molina, MD, Protagonist Therapeutics, discusses results from the phase 2 REVIVE clinical trial testing rusfertide in patients with polycythemia vera (PV).     PV is a myeloproliferative disorder characterized by an elevated absolute red blood cell...